CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 4 Open-market sale Chief Operating Officer sold 3,499 shares at $5.33 ($18,642)
- 4 Open-market sale Chief Medical Officer sold 845 shares at $5.33 ($4,502)
- 4 Open-market sale Chief Executive Officer sold 4,967 shares at $5.33 ($26,464)
- 4 Open-market buy Chief Financial Officer bought 24,000 shares at $0.69 ($16,550)
- 8-K Event Executive or director change
- 4 Open-market buy Chief Operating Officer bought 207,000 shares at $0.69 ($143,824)
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- CT ORDER Other Confidential Order
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Chief Executive Officer sold 2,776 shares at $8.51 ($23,637)
- 8-K Event Regulation FD disclosure
- S-3ASR Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Patient Supply Officer sold 4,823 shares at $9.25 ($44,613)
- 4 Open-market sale Chief Business Officer sold 200,000 shares at $8.74 ($1,748,180)
Page 18 of 41 · 808 filings